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phoria (The relieving prism to bring a vertical fixation disparity to zero). It is generally accepted that the 
most accurate device used to measure fixation disparity at nearpoint is the Sheedy disparometer. 
However, the Sheedy disparometer is relatively large, expensive and not currently manufactured. These 
factors may make measurements of vertical associated phorias less appealing and accessible to 
practitioners. This study evaluated the vertical associated phoria measurements of twenty non-
asthenopic subjects with measurable vertical phorias. Vertical associated phoria measurements were 
made using the Sheedy disparometer and a unique inexpensive anaglyphic vertical fixation disparity test 
composed of a card with a specifically designed red and green image and a pair of standard anaglyphic 
glasses for the patient to wear. Both tests at 40 em and were administered in an equally randomized 
order. The results indicate that vertical associated phoria measurements with the anaglyphic test are 
statistically equivalent to the Sheedy disparometer (mean difference = 0.00; p= value >0.9999). Based on 
this study, this inexpensive anaglyphic card can be used to confidently derive an accurate vertical 
associated phoria value for vertical prism prescriptions. Other clinical considerations are discussed. 
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Abstract 
The clinical gold standard for deriving vertical prism prescriptions is the 
patient's vertical associated phoria (The relieving prism to bring a vertical 
fixation disparity to zero). 1•2•5•9•12•15 It is generally accepted that the most 
accurate device used to measure fixation disparity at nearpoint is the Sheedy 
disparometer. However, the Sheedy disparometer is relatively large, expensive 
and not currently manufactured. These factors may make measurements of 
vertical associated phorias less appealing and accessible to practitioners. 
This study evaluated the vertical associated phoria measurements of 
twenty non-asthenopic subjects with measurable vertical phorias. Vertical 
associated phoria measurements were made using the Sheedy disparometer 
and a unique inexpensive anaglyphic vertical fixation disparity test composed 
of a card with a specifically designed red and green image and a pair of 
standard anaglyphic glasses for the patient to wear. Both tests at 40 em and 
were administered in an equally randomized order. The results indicate that 
vertical associated phoria measurements with the anaglyphic test are 
statistically equivalent to the Sheedy disparometer (mean difference = 0.00; p= 
value >0.9999). Based on this study, this inexpensive anaglyphic card can be 
used to confidently derive an accurate vertical associated phoria value for 
vertical prism prescriptions. Other clinical considerations are discussed. 
1 
Introduction 
Fixation disparity is a measure of the residual misalignment of the visual 
axes during bifoveal fixation. The measurement of fixation disparity and the 
vertical associated phoria (VAP) are essential tools available to optimally and 
accurately manage patients with vertical fusion deviations. It is imperative that 
before prescribing vertical prism the practitioner needs to determine etiology, 
measurement variability, comitancy, prism adaptation, and VAP. 1 According to 
Scheiman and Wick, the VAP has become the standard method for the 
prescribing of vertical prism over the past 30 years. 10 
In theory, any small misalignment between the visual axes would result 
in diplopia. 11 However, due to Panum's fusional areas, similar images that fall 
on small corresponding regions of each visual field will be perceived as single. 
Without it each eye would have to be precisely aimed in order to maintain 
single binocular vision. This area, therefore, allows a little "slop" in our 
vergence system.6•7•13 Fixation disparity is also considered to be a meaningful 
cue to regulate and stabilize vergence during sustained viewing. 1·6 For 
instance, when a patient with an exo fixation disparity focuses on a near object 
their eyes tend posture slightly behind the object of regard. The small disparity 
then stimulates a continual positive convergence response which helps in 
maintaining the object of regard as single. Similarly, with an eso fixation 
disparity the eyes tend to posture slightly in front of an object, in this case a 
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negative fusional response is elicited which helps maintain single binocular 
vision. This concept applies to vertical Vergence adjustments as well. 
Any small misalignment in the visual axes can manifest as visual 
complaints, especially in the vertical meridian.1.6 Depending upon the nature 
and degree of a vertical fixation disparity, the clinician can provide great relief 
through the use of prism and/or vision therapy techniques. Eskridge and 
Rustein determined in a clinical evaluation of VFD that prism should only be 
prescribed to those who don't adapt, otherwise there is no benefit. They 
discovered the majority of patients that prism adapt are asymptomatic, or 
better treated with methods such as vision therapy.5 Prism adaptation can be 
predicted by generation of a vertical FD curve or tested via trial wear of the 
VAP. Although techniques for testing prism adaptation vary slightly in detail, 
the process follows these general steps; have the patient wear the prism to be 
prescribed in a trial frame for 1 0 to 30 minutes. 1 If a patient adapts readily to 
the VAP (returns to the original value), the relief from applying prism cannot be 
expected to sustain. If a patient does not adapt (or only adapts slightly), a 
prism Rx can be applied with more confidence of sustained benefit over time. 
Therefore, the measurement of VAP is an almost indispensable tool in the 
process of choosing to provide a vision therapy regimen and/or prescribing 
prism.6 
Most clinical methods employed to measure fixation disparity utilize 
polarized filters to isolate the image to each eye. Commonly used devices 
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include the Sheedy Disparometer, the Saladin Nearpoint Card and Wesson 
card which can quantify the value of the FD. Other devices which allow 
detection (not measurement) of FD and measurement of VAP include 
vectographic projection slides. 1·2·13•15 Therefore, this type of target will not 
allow generation of fixation disparity curves, which is clinically more 
troublesome when dealing with horizontal vergence problems. 
Once a vertical fixation disparity is found, the clinician can subsequently 
measure the VAP through careful application of relieving prism until the FD 
becomes zero. The amount of prism that allows the fixation disparity to reduce 
to zero is the value of the vertical associated phoria (VAP). The patient 
indicates the VAP is found when vernier alignment of two horizontal lines is 
achieved. 13 
Vertical and horizontal vergence skills can be analyzed by plotting a FD 
curve. These curves can help determine the amount of prism to prescribe and 
whether or not it is likely the patient will adapt. Unlike horizontal curves, 
vertical curves usually only show a narrow "flat" region in the otherwise almost 
linear slope. This indicates patients are much less likely to adapt to vertical 
disparities, which means a small vertical disparity could possibly result in 
asthenopia. However, it has been shown that the "flat", prism-tolerant region 
can be expanded and flattened with vision therapy in patients with normal 
prism adaptation.8 Thus it is of the utmost importance in a general vision 
examination to either routinely utilize vertical FD testing as a screening tool, or 
4 
apply vertical FD testing whenever a vertical deviation is discovered by a 
routinely applied test (such as Maddox rod) or suspected based on case 
history. 
Although the application of vertical fixation disparity detection and VAP 
measurement to generation of a vertical prism prescription is well documented 
to be the ideal clinical approach, the majority of practitioners do not utilize 
vertical fixation disparity information in their exam sequence. 7 This is likely 
due to the price of the testing devices, lack of knowledge that some of the 
devices exist, or perceptions of how long FD testing will take. This has lead 
the authors to develop an anaglyphic target on a standard size nearpoint card 
which can be used to detect vertical fixation disparity and allow measurement 
ofVAP. 
5 
The Anaglyphic Target Nearpoint Card 
If patients can perform the test using standardized instructions and the VAP 
results are equivalent to those derived from a currently accepted clinical 
method, practitioners would have a low-cost, easily stored and held device for 
gathering these essential measurements. 
This study is designed to compare vertical AP measurements from the 
experimental anaglyphic card to those measured with the Sheedy 
Disparometer. 
6 
Methods 
Twenty subjects (ages 18 to 55) with vertical dissociated phorias were 
identified for the study. The presence of a vertical dissociated phoria was 
confirmed by either standard von Grafe testing in phoropter or cover test. 
Inclusion criteria for each subject were the following: near visual acuity of 
20/20 or better in each eye when measured under standard clinical protocols, 
no ocular disease or media opacities, no strabismus, and asymptomatic near 
vision. 
The experimental anaglyphic card has a round central target that is 
9mm in diameter. The outer circumference of the target is a black ring that is 
0.75mm thick. The left half of the target within the black ring is green and the 
right half is red. When one eye is closed, the other eye should see black on 
the opposite side of the circle target and vice versa; they have to cancel for an 
accurate measurement of associated phoria and fixation disparity. Standard 
near point lighting was used when the red and green were properly tuned 
through trial and error for optimal cancellation with standard anaglyphic 
glasses. Two horizontal lines are used to measure the VAP. Each line is 3mm 
long and 0.50mm thick. There is 0.50mm of space between the outer edge of 
the line and the outer black ring and 1 mm of space between the lines (0.50mm 
of space within each color zone). These specifications were chosen to 
approximate the features of the disparometer. 
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The subjects were familiarized with vertical fixation disparity testing 
procedures for both the Sheedy Disparometer and the experimental 
Anaglyphic card. The subject was informed, 'This is a device to measure how 
your two eyes aim together. Do you see these two horizontal lines? I am 
going to have you wear these glasses and tell me when the lines are perfectly 
level with each other, when the right line is above the left line, or when the 
right line is below the left line." To sensitize the patient to a change in disparity, 
2 prism diopters base up and down were applied by holding up loose prism 
over the subject's right eye with both targets before testing started. 
Both tests were administered in a randomized order. All testing was out 
of phoropter at 40cm with standard near point overhead lighting. The 
anaglyphic glasses were worn with the red filter on the subject's right eye and 
the green filter on the subject's left eye for the anaglyphic card. The cards 
were held straight and steady by the examiner at the measured 40cmduring 
testing. This helped standardize protocols for testing vertical alignment as well 
as maintain consistent cancellation when using the polarized target of the 
Sheedy Disparometer. 
The subject was instructed to gaze out towards a hanging standard 
Snellen chart at 6 meters with their habitual prescription for 1 0 seconds, and 
then look at the near test. The subject was instructed to try to keep the letters 
clear to the right and left of the lines while noticing the horizontal lines and any 
disparity.4·14 Next, the subject had to respond whether the line on the right-
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hand side was 'equal', 'above', or 'below' within 10 seconds or the process 
was repeated. If a disparity between the two lines was reported, the test was 
repeated with compensating prism over the right eye in increasing 0.5il 
increments until no fixation disparity was reported. Care was taken to assure 
that the prism was held with the base exactly up or down with no rotation 
which would reduce the effective vertical prism power applied. Each time the 
test conditions were modified, the subject was instructed to look at the 6-meter 
chart and then look back to the test. Three VAP measurements were taken 
with each device. These values were averaged for each subject, and these 
averages were used for statistical comparison. 
Results 
The averages for each subject are presented in table "Measured VAP". 
Simply scanning the results for each subject shows that the average VAP 
prism value is easily within clinical acceptability. The largest difference 
between the two testing conditions for an individual subject was 0.33 prism 
diopters (occurred in two of twenty subjects). By practical clinical 
consideration, this maximum difference is not ideal, but is reasonable when 
approaching a vertical prism prescription. 
The collected data was analyzed using a paired t-test. The mean value 
measured with the Sheedy disparometer was found to be 0.03 ± 0.81, 
whereas the mean value obtained with the anaglyphic card was 0.03 ± 0.85. 
The mean difference of the two test conditions was 0.00 ± 0.13. The analysis 
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of this data provided p >0.9999. It was determined that the two test conditions 
did not prove statistically different. Thus, according to our data the anaglyphic 
card gives a statistically equivalent measurement to the Sheedy Disparometer. 
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Subject Sheedy Disparometer Ana glyphic 
(Avg . .6.) Card (Avg . .6.) 
1 -0.83 -0.83 
2 1 0.83 
3 -1 -1 
4 0.5 0.5 
5 -1 -1 
6 1.5 1.5 
7 0.5 0.5 
8 0.5 0.5 
9 -0.5 -0.5 
I 
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• Anaglyphic 
Card 
Difference of 
Measurements (.6.) 
0 
-0.17 
0 
0 
0 
0 
0 
0 
0 
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10 0.5 0.5 0 
11 -0.83 -1 -0 .17 
12 0.5 0.83 0.33 
13 0.33 0.5 0.17 
14 -1 -1 0 
15 -0.83 -0.83 0 
16 1 1 0 
17 -0.5 -0.83 -0.33 
18 0.5 0.5 0 
19 0.83 1 0.17 
20 -0.5 -0.5 0 
Mean 0.03 0.03 0.00 
Standard Deviation 0.81 0.85 0.13 
*Negative values indicate "Left Hyper", Positive values indicate "Right Hyper" 
Discussion 
Results from this study indicate the experimental anaglyphic card and 
the Sheedy vertical fixation disparity test provide clinically and statistically 
equivalent VAP results. This illustrates that the experimental card can 
confidently be utilized in clinical care where FD detection and/or VAP 
measurement is indicated. 
The most efficient practitioners perform a problem-focused exam when 
time is of the essence. Based on plentiful evidence in optometric literature and 
clinical experience, the authors feel VAP this is the most clinically useful piece 
of data to predict an optimal vertical prism prescription or, through 
consideration of prism adaptation, lead to a viable vision therapy program. 
Additionally, applying the VAP when prescribing vertical prism might actually 
be cost effective with fewer prescription redos than might occur with less 
precise prism estimation methods. 
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As the experimental card is an inexpensive, easily stored, easily held 
item that is quick and easy for the patient and doctor to use, the anaglyphic 
card should allow practitioners in essentially any practice setting to gather VAP 
measurements without undue expense or chair-time. This, in turn, will allow 
the practitioner to make optimal decisions about the care of patients with 
vertical vergence deviations. 
Challenges of the study included designing a red/green card which 
would provide VAP results equivalent to the current clinical gold standard, the 
polarized Sheedy disparometer. Details of the card design can be found in the 
methods section. 
An anticipated challenge that did not present itself during this study was 
that of suppression. The anaglyphic glasses could cause suppression to occur 
more easily than the polarized glasses. The higher the contrast, the least 
likely suppression will occur.6 The anaglyphic glasses reduce contrast slightly 
more than polarized glasses when testing. Additionally, the dioptric difference 
between the red and green sides (varies by exact filter colors, but is 
approximately 0.37 diopters from red to green), and the different colors 
themselves could create enough rivalry to encourage a patient with unstable 
sensory fusion to suppress during the test. Suppression would have caused 
one line to become absent or fade in and out during testing. No subjects 
reported any symptoms of suppression. In order to break suppression, the 
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subject would have been instructed to blink or wave a finger in front of their 
eyes. 
The study did not include full vertical fixation disparity cuNe generation. 
Future studies could include designing cards with known arc minute of line 
misalignment to allow the patient to identify the fixation disparity value with 
each prism application. Results from vertical FD curves could be compared 
using anaglyphic and polarized methods. If adequate accommodative controls 
were incorporated, the results of horizontal FD testing could also be compared 
using anaglyphic and polarized targets. However, the dioptric difference 
between the red and green filters might introduce more accommodation 
inaccuracy or fluctuation, potentially making horizontal FD testing difficult for 
the patient and less reliable for the practitioner. 
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